Case builds for Biogen, Stoke's Dravet syndrome drug
Hopes have risen for a new treatment for severe childhood epilepsy Dravet syndrome, on the back of new data for Biogen and Stoke's zorevunersen.
AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody
AbbVie has signed another deal in its effort to build an industry-leading position in multispecific antibodies for blood cancers.
Bayer bags first world approval for hot flush therapy
Bayer has its first regulatory approval for non-hormonal menopause treatment elinzanetant – in the UK – as it chases down a rival drug from Astellas.
Cash injection will help Varda make drugs in space
A new US startup, called Varda Space Industries, has raised $187 million in financing for a bold plan to manufacture medicines in orbit.
Just how radical is the FDA's complete response letter move?
The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
Immune Cell Engager Partnering & Investment Summit
Driving high ROI across immune cell engagers through strategic partnerships & investments, capitalizing on novel targets & asset tunability...
2nd ADC & Novel Conjugates Partnering & Investment Summit
Refine your strategy, sharpen your positioning, and meet the right partners - all at the most efficient networking event of the ADCconference calendar
2nd Autoimmunity & Inflammation Partnering & Investment Summ...
Driving deal-making across targeted cell depletion, checkpoint agonism, tolerance, and oral anti-inflammatory biologics...
Welcome to the 2nd Raw Materials for Cell & Gene Therapy Sum...
Streamline Supply Chain Communications to Optimize Phase Appropriate QC Testing, Comparability & GMP Manufacturing of Raw Materials...
Network With EHS Professionals - EHS&S for Biopharma West
Advancing Biosafety & Sustainability in R&D & Manufacturing